Federated Hermes
ATOS icon

Federated Hermes’s Atossa Therapeutics ATOS Stock Holding History

Federated Hermes’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed -$1K – 2162
2022
Q3 		$1K Hold
45
– – ﹤0.01% 2006
2022
Q2 		$1K Buy
+45
New +$709 ﹤0.01% 2022
2021
Q3 		– Sell
-9
Closed -$1K – 2211
2021
Q2 		$1K Buy
+9
New +$476 ﹤0.01% 2113

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Federated Hermes's ATOS Position: Q4 2022 in Review

Federated Hermes sold out of Atossa Therapeutics (ATOS) in Q4 2022, closing a stake of 45 shares — an estimated $1K sold.

Federated Hermes first reported a position in ATOS in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 51 funds tracked by Wall St. Rank hold ATOS as of Q4 2022.

  • Federated Hermes reported no remaining Atossa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Federated Hermes sold 45 Atossa Therapeutics shares in Q4 2022, an estimated $1K.
  • Federated Hermes first reported a position in Atossa Therapeutics in Q2 2021 and held it in 3 quarters.
  • Federated Hermes's Atossa Therapeutics position peaked at $1K in Q3 2022.
  • 51 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.